Emergent BioSolutions (EBS) Misses Q1 EPS by 25c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $8.28 --0%
EPS Growth %: -31.3%
Financial Fact:
Weighted-average number of shares - basic: 40.47M
Today's EPS Names:
More
EPS Growth %: -31.3%
Financial Fact:
Weighted-average number of shares - basic: 40.47M
Today's EPS Names:
More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of ($0.03), $0.25 worse than the analyst estimate of $0.22. Revenue for the quarter came in at $117.8 million versus the consensus estimate of $140.42 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
- Six Flags names Mark Pauls as chief operating officer
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
